No abstract available
MeSH terms
-
Antiparkinson Agents / therapeutic use
-
Cholinesterase Inhibitors / adverse effects
-
Cholinesterase Inhibitors / therapeutic use*
-
Dementia / drug therapy*
-
Dementia / etiology
-
Disease Progression
-
Humans
-
Lewy Body Disease / drug therapy*
-
Nausea / chemically induced
-
Parkinson Disease / complications
-
Parkinson Disease / drug therapy*
-
Phenylcarbamates / adverse effects
-
Phenylcarbamates / therapeutic use*
-
Rivastigmine
Substances
-
Antiparkinson Agents
-
Cholinesterase Inhibitors
-
Phenylcarbamates
-
Rivastigmine